Global Male Infertility Market Forecast 2023-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,900	238 Pages	Inkwood Research	May, 2023	INKR17955503

Best Price Guarantee
Price	from $2,900
Length	238 Pages
Publisher	Inkwood Research
Published Date	May, 2023
SKU	INKR17955503

Global Male Infertility Market Forecast 2023-2032

KEY FINDINGS

The global male infertility market is predicted to record a 4.53% CAGR during the forecast period from 2023 to 2032. Surging incidences of infertility, adoption of assisted reproductive technologies, and technological advancements boost the market growth globally.

MARKET INSIGHTS

Several significant factors drive the growth of the global male infertility market, including issues with sperm production or delivery, such as low sperm count, abnormal sperm function, or blockages, commonly cause male infertility. Additionally, illnesses, chronic health problems, injuries, lifestyle choices, and other factors contribute to male infertility.

The surging incidence of infertility and the adoption of assisted reproductive technologies (ART) are crucial in addressing male infertility challenges. Assisted reproductive technologies provide a viable solution for men facing infertility issues, offering higher success rates compared to medications. The widespread adoption of these technologies has increased pregnancy possibilities for infertile couples worldwide, contributing to the growth of the male infertility market.

REGIONAL INSIGHTS

The global male infertility market evaluation comprises a study of Asia-Pacific, North America, Europe, and Rest of World. Europe is estimated to dominate in terms of market share owing to the increased adoption of affordable therapies and devices, assisted reproductive technologies, and reimbursement coverage.

COMPETITIVE INSIGHTS

The global male infertility market is characterized by intense competition due to the presence of numerous companies. These companies strive to develop innovative products for infertility treatment, and regional players compete with established brands. Market players focus on conducting clinical trials, developing new products, and launching novel solutions to gain a competitive edge.

Leading market players include CinnaGen Co, Endo International PLC, Caerus Biotech, EMD Serono Inc (Merck Serono), etc.

Our report offerings include:

• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. Research Scope & Methodology: 1.1. Study Objectives; 1.2. Methodology; 1.3. Assumptions & Limitations
2. Executive Summary: 2.1. Market Size & Estimates; 2.2. Market Overview; 2.3. Scope Of Study; 2.4. Crisis Scenario Analysis; 2.5. Major Market Findings; 2.5.1. Product Developments And Launches By Market Players Promote Market Growth; 2.5.2. Prevalence Of Diabetes And Cancer
3. Market Dynamics: 3.1. Key Drivers; 3.1.1. Surging Infertility Incidences; 3.1.2. Assisted Reproductive Technology Adoption; 3.1.3. Technological Advancements; 3.2. Key Restraints; 3.2.1. High Treatment Costs
4. Key Analytics: 4.1. Key Market Trends; 4.2. Porter’s Five Forces Analysis; 4.2.1. Buyers Power; 4.2.2. Suppliers Power; 4.2.3. Substitution; 4.2.4. New Entrants; 4.2.5. Industry Rivalry; 4.3. Growth Prospect Mapping; 4.4. Market Maturity Analysis; 4.5. Market Concentration Analysis
5. Market By Test Type: 5.1. Dna Fragmentation Technique; 5.2. Oxidative Stress Analysis; 5.3. Microscopic Examination; 5.4. Sperm Agglutination; 5.5. Computer-assisted Semen Analysis; 5.6. Sperm Penetration Assay; 5.7. Other Test Types
6. Market By Treatment: 6.1. Assisted Reproductive Technology And Surgery; 6.2. Medications
7. Geographical Analysis: 7.1. North America; 7.1.1. Market Size & Estimates; 7.1.2. North America Male Infertility Market Drivers; 7.1.3. North America Male Infertility Market Challenges; 7.1.4. Key Players In North America Male Infertility Market; 7.1.5. Country Analysis; 7.1.5.1. United States; 7.1.5.1.1. United States Male Infertility Market Size & Opportunities; 7.1.5.2. Canada; 7.1.5.2.1. Canada Male Infertility Market Size & Opportunities; 7.2. Europe; 7.2.1. Market Size & Estimates; 7.2.2. Europe Male Infertility Market Drivers; 7.2.3. Europe Male Infertility Market Challenges; 7.2.4. Key Players In Europe Male Infertility Market; 7.2.5. Country Analysis; 7.2.5.1. United Kingdom; 7.2.5.1.1. United Kingdom Male Infertility Market Size & Opportunities; 7.2.5.2. Germany; 7.2.5.2.1. Germany Male Infertility Market Size & Opportunities; 7.2.5.3. France; 7.2.5.3.1. France Male Infertility Market Size & Opportunities; 7.2.5.4. Italy; 7.2.5.4.1. Italy Male Infertility Market Size & Opportunities; 7.2.5.5. Spain; 7.2.5.5.1. Spain Male Infertility Market Size & Opportunities; 7.2.5.6. Belgium; 7.2.5.6.1. Belgium Male Infertility Market Size & Opportunities; 7.2.5.7. Poland; 7.2.5.7.1. Poland Male Infertility Market Size & Opportunities; 7.2.5.8. Rest Of Europe; 7.2.5.8.1. Rest Of Europe Male Infertility Market Size & Opportunities; 7.3. Asia-pacific; 7.3.1. Market Size & Estimates; 7.3.2. Asia-pacific Male Infertility Market Drivers; 7.3.3. Asia-pacific Male Infertility Market Challenges; 7.3.4. Key Players In Asia-pacific Male Infertility Market; 7.3.5. Country Analysis; 7.3.5.1. China; 7.3.5.1.1. China Male Infertility Market Size & Opportunities; 7.3.5.2. Japan; 7.3.5.2.1. Japan Male Infertility Market Size & Opportunities; 7.3.5.3. India; 7.3.5.3.1. India Male Infertility Market Size & Opportunities; 7.3.5.4. South Korea; 7.3.5.4.1. South Korea Male Infertility Market Size & Opportunities; 7.3.5.5. Indonesia; 7.3.5.5.1. Indonesia Male Infertility Market Size & Opportunities; 7.3.5.6. Thailand; 7.3.5.6.1. Thailand Male Infertility Market Size & Opportunities; 7.3.5.7. Vietnam; 7.3.5.7.1. Vietnam Male Infertility Market Size & Opportunities; 7.3.5.8. Australia & New Zealand; 7.3.5.8.1. Australia & New Zealand Male Infertility Market Size & Opportunities; 7.3.5.9. Rest Of Asia-pacific; 7.3.5.9.1. Rest Of Asia-pacific Male Infertility Market Size & Opportunities; 7.4. Rest Of World; 7.4.1. Market Size & Estimates; 7.4.2. Rest Of World Male Infertility Market Drivers; 7.4.3. Rest Of World Male Infertility Market Challenges; 7.4.4. Key Players In Rest Of World Male Infertility Market; 7.4.5. Regional Analysis; 7.4.5.1. Latin America; 7.4.5.1.1. Latin America Male Infertility Market Size & Opportunities; 7.4.5.2. Middle East & Africa; 7.4.5.2.1. Middle East & Africa Male Infertility Market Size & Opportunities
8. Competitive Landscape: 8.1. Key Strategic Developments; 8.1.1. Mergers & Acquisitions; 8.1.2. Product Launches & Developments; 8.1.3. Partnerships & Agreements; 8.1.4. Business Expansions; 8.2. Company Profiles; 8.2.1. Advacare Pharma Usa; 8.2.1.1. Company Overview; 8.2.1.2. Products / Services List; 8.2.2. Andrology Solutions; 8.2.2.1. Company Overview; 8.2.2.2. Products / Services List; 8.2.3. Aytu Biopharma; 8.2.3.1. Company Overview; 8.2.3.2. Products / Services List; 8.2.3.3. Strengths & Challenges; 8.2.4. Bayer Group; 8.2.4.1. Company Overview; 8.2.4.2. Products / Services List; 8.2.4.3. Strengths & Challenges; 8.2.5. Caerus Biotech; 8.2.5.1. Company Overview; 8.2.5.2. Products / Services List; 8.2.6. Cinnagen Co; 8.2.6.1. Company Overview; 8.2.6.2. Products / Services List; 8.2.6.3. Strengths & Challenges; 8.2.7. Emd Serono Inc (Merck Serono); 8.2.7.1. Company Overview; 8.2.7.2. Products / Services List; 8.2.7.3. Strengths & Challenges; 8.2.8. Endo International Plc; 8.2.8.1. Company Overview; 8.2.8.2. Products / Services List; 8.2.8.3. Strengths & Challenges; 8.2.9. Halotech Dna; 8.2.9.1. Company Overview; 8.2.9.2. Products / Services List; 8.2.10. Laboratory Corporation Of America Holdings; 8.2.10.1. Company Overview; 8.2.10.2. Products / Services List; 8.2.10.3. Strengths & Challenges; 8.2.11. Sanofi; 8.2.11.1. Company Overview; 8.2.11.2. Products / Services List; 8.2.11.3. Strengths & Challenges; 8.2.12. Scsa Diagnostics; 8.2.12.1. Company Overview; 8.2.12.2. Products / Services List; 8.2.13. Theramex; 8.2.13.1. Company Overview; 8.2.13.2. Products / Services List; 8.2.14. Vitrolife; 8.2.14.1. Company Overview; 8.2.14.2. Products / Services List; 8.2.14.3. Strengths & Challenges; 8.2.15. Zydus Lifesciences Ltd (Cadila Healthcare Ltd); 8.2.15.1. Company Overview; 8.2.15.2. Products / Services List; 8.2.15.3. Strengths & Challenges